← back to search

E. Ray Dorsey

Global Brain Health Institute · US
Area of research
Neurology · Economics and Econometrics
Research interest
Research interests include Parkinson's Disease Mechanisms and Treatments, Health Systems, Economic Evaluations, Quality of Life, Voice and Speech Disorders, and Telemedicine and Telehealth Implementation.
h-index
60
citations
24,112
works
245
NIH funding
primary concept
Medicine
email

Recent publications

Validation of remote multimodal AI screening for Parkinson disease across diverse settings.
2026cited by 0position: contributordoi
Environmental toxicants and Parkinson's disease: recent evidence, risks, and prevention opportunities
The Lancet Neurology 2025cited by 19position: firstdoi
Using wearable sensors and machine learning to assess upper limb function in Huntington's disease.
2025cited by 5position: contributordoi
AI-Enabled Parkinson’s Disease Screening Using Smile Videos
NEJM AI 2025cited by 2position: contributordoi
Locally adapting digital health technologies to address the global challenge of Parkinson’s disease
Equity Neuroscience 2025cited by 2position: contributordoi
Trichloroethylene and Parkinson Disease.
2025cited by 0position: contributordoi
A PLAN to address the Parkinson pandemic.
2025cited by 0position: contributordoi
Improving Prediction of Falls and Cognitive Impairment in Parkinson Disease: Protocol for a Decentralized Observational Study.
2025cited by 0position: contributordoi
Improving Prediction of Falls and Cognitive Impairment in Parkinson Disease: Protocol for a Decentralized Observational Study (Preprint)
2025cited by 0position: contributordoi
Remote AI Screening for Parkinson's Disease: A Multimodal, Cross-Setting Validation Study
2025cited by 0position: contributordoi
Using a smartwatch and smartphone to assess early Parkinson’s disease in the WATCH-PD study over 12 months
npj Parkinson s Disease 2024cited by 53position: middledoi
Using a smartwatch and smartphone to assess early Parkinson's disease in the WATCH-PD study over 12 months.
2024cited by 33position: contributordoi
The Body, the Brain, the Environment, and Parkinson’s Disease
Journal of Parkinson s Disease 2024cited by 32position: firstdoi
Improved measurement of disease progression in people living with early Parkinson's disease using digital health technologies.
2024cited by 12position: contributordoi
Dry-Cleaning Chemicals and a Cluster of Parkinson's Disease and Cancer: A Retrospective Investigation.
2024cited by 4position: contributordoi
Using a Smartwatch and Smartphone to Assess Early Parkinson’s Disease in the WATCH-PD Study – 12-month results
2024cited by 1position: contributordoi
Using a smartwatch and smartphone to assess early Parkinson’s disease in the WATCH-PD study
npj Parkinson s Disease 2023cited by 89position: middledoi
Trichloroethylene: An Invisible Cause of Parkinson’s Disease?
Journal of Parkinson s Disease 2023cited by 68position: firstdoi
Using a smartwatch and smartphone to assess early Parkinson's disease in the WATCH-PD study.
2023cited by 63position: contributordoi
Towards interpretable speech biomarkers: exploring MFCCs
Scientific Reports 2023cited by 36position: middledoi
Using AI to measure Parkinson's disease severity at home.
2023cited by 31position: contributordoi
Paraquat, Parkinson's Disease, and Agnotology.
2023cited by 9position: contributordoi
A User-Centered Framework to Empower People with Parkinson's Disease
Proceedings of the ACM on Interactive, Mobile, Wearable and Ubiquitous Technologies 2023cited by 9position: contributordoi
Retraction Note: Facial expressions can detect Parkinson's disease: preliminary evidence from videos collected online.
2023cited by 0position: contributordoi
Enhanced sensitivity to disease progression using digital health technologies in early Parkinson’s disease
2023cited by 0position: contributordoi
Six Action Steps to Address Global Disparities in Parkinson Disease
JAMA Neurology 2022cited by 138position: middledoi
Monitoring gait at home with radio waves in Parkinson’s disease: A marker of severity, progression, and medication response
Science Translational Medicine 2022cited by 105position: middledoi
Remote smartphone monitoring of Parkinson's disease and individual response to therapy.
2022cited by 89position: contributordoi
Monitoring gait at home with radio waves in Parkinson's disease: A marker of severity, progression, and medication response.
2022cited by 61position: contributordoi
Identifying and characterising sources of variability in digital outcome measures in Parkinson's disease.
2022cited by 15position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 34 papers (2020–2026)Ruth B Schneider · University of Rochester Medical Center10 papers (2021–2026)Jamie L. Adams · Rochester Institute of Technology9 papers (2021–2025)Bastiaan R. Bloem · University of Lausanne8 papers (2014–2025)Caroline M. Tanner · San Francisco VA Medical Center7 papers (2014–2025)Md Saiful Islam · University of Rochester7 papers (2021–2026)Tanya Simuni · Indiana University – Purdue University Indianapolis5 papers (2021–2025)Joshua Cosman · Biogen (United States)5 papers (2022–2024)Sangwu Lee · University of Rochester5 papers (2021–2025)Max A. Little · Massachusetts Institute of Technology5 papers (2015–2021)Ruth B. Schneider · Columbia University5 papers (2018–2023)Kevin Biglan · Eli Lilly (United States)5 papers (2012–2016)Jamie Adams · University of Rochester Medical Center5 papers (2018–2023)Christopher G. Tarolli · University of Rochester Medical Center4 papers (2018–2022)Karlo J. Lizárraga · John Wiley & Sons (United States)4 papers (2021–2025)Mohammad Rafayet Ali · University of Rochester4 papers (2021–2023)Tariq Adnan · Bangladesh University of Engineering and Technology4 papers (2023–2026)Emma Waddell · Brigham and Women's Hospital4 papers (2021–2023)Meghan Pawlik · Hamilton College4 papers (2021–2024)Wasifur Rahman · University of Rochester4 papers (2021–2025)